Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Peginterferon alpha 2a
DRUG
3 trials
Sponsors
Foundation for Liver Research
, University of Nebraska
, Beijing Ditan Hospital
Conditions
Chronic Hepatitis B
Chronic Hepatitis C
Genotype 1
Hepatitis B
Relapse
Early Phase 1
Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/Relapsers
Terminated
NCT00882193
University of Nebraska
Chronic Hepatitis C, Genotype 1, Relapse
Start: 2009-05-01
End: 2011-01-12
Updated: 2023-11-30
Phase 3
48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection
Completed
NCT00114361
Foundation for Liver Research
Hepatitis B
Start: 2005-03-31
End: 2010-04-30
Updated: 2010-06-22
Phase 4
Efficacy of Peginterferon Alpha 2a Therapy in Chronic Hepatitis B Patients Being Treated With Nucleoside(Acid) Analogues
NCT02362490
Beijing Ditan Hospital
Chronic Hepatitis B
Start: 2013-01-31
End: 2016-12-31
Target: 200
Updated: 2016-09-13
Related Papers
End-of-treatment HBsAg, HBcrAg and HBV RNA predict the risk of off-treatment ALT flares in chronic hepatitis B patients.
2022-07-02
17 citations
Levels of Antibodies to Hepatitis B Core Antigen Are Associated With Liver Inflammation and Response to Peginterferon in Patients With Chronic Hepatitis B
The Journal of Infectious Diseases
2022-05-23
19 citations
Hepatitis B virus RNA decline without concomitant viral antigen decrease is associated with a low probability of sustained response and hepatitis B surface antigen loss
Alimentary Pharmacology & Therapeutics
2020-11-21
24 citations
Hepatitis B Virus RNA as Early Predictor for Response to Pegylated Interferon Alpha in HBeAg-Negative Chronic Hepatitis B
Clinical Infectious Diseases
2020-01-06
69 citations